Cm Tx Biotech
Biotechnology, 25 Health Sciences Drive, Stony Brook, New York, 07105, United States, 1-10 Employees
Phone Number: 63********
Who is CMTX BIOTECH
CMTx Biotech is commercializing a pipeline of proprietary, non-antibiotic, chemically-modified tetracycline (CMT) compositions and formulations for the host-modulatory treatment of diseas...
Read More
- Headquarters: 25 Health Sciences Drive, Stony Brook, New York, 07105, United States
- Date Founded: 2019
- Employees: 1-10
- Revenue: $5 Million to $10 Million
- Active Tech Stack: See technologies
- CEO: Joseph Scaduto
Industry: Biotechnology
SIC Code: 2836 | NAICS Code: 541714 | Show More
Does something look wrong? Fix it. | View contact records from CMTX BIOTECH
CMTx Biotech Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding CMTx Biotech
Answer: CMTx Biotech's headquarters are located at 25 Health Sciences Drive, Stony Brook, New York, 07105, United States
Answer: CMTx Biotech's phone number is 63********
Answer: CMTx Biotech's official website is https://cmtxbiotech.com
Answer: CMTx Biotech's revenue is $5 Million to $10 Million
Answer: CMTx Biotech's SIC: 2836
Answer: CMTx Biotech's NAICS: 541714
Answer: CMTx Biotech has 1-10 employees
Answer: CMTx Biotech is in Biotechnology
Answer: CMTx Biotech contact info: Phone number: 63******** Website: https://cmtxbiotech.com
Answer: CMTx Biotech is commercializing a pipeline of proprietary, non-antibiotic, chemically-modified tetracycline (CMT) compositions and formulations for the host-modulatory treatment of diseases with high unmet needs. The companys lead drug candidate is a clinical-stage, orally-administered small molecule (incyclinide / CMT-3 / COL-3) for the treatment of hospitalized sepsis patients at risk of septic shock, multiple organ dysfunction syndrome (MODS) and acute respiratory distress syndrome (ARDS), including from SARS-CoV-2 infection (COVID-19) and other infectious diseases. Our clinical-stage drug candidate has already demonstrated impressive efficacy in a number of animal models of sepsis/ARDS/MODS across multiple species (rats, mice, pigs, sheep). It has also been evaluated in over 450 patients across eleven Phase I/II clinical studies, which showed that the drug is well-tolerated. CMTx Biotech also has a pipeline of pre-clinical stage analogues for the treatment of diseases with high unmet need.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month